The top ten factors for employers when considering GLP-1 coverage for weight loss are: Obesity as a risk factor for chronic diseases and associated costs53% Long-term costs and difficulty measuring outcomes38% Impact/effectiveness of cost-control mechanisms on health insurance premiums38% Medication adherence factors25% Immediate/short-term costs25% Broker/consultant/PBM recommendations25% Patient and prescriber demand22% Oral pill forms available22% GLP-1 label expansion/approval for secondary conditions22% Side effects19%
I.V., Intravenous
This argument is incorrect and treating obesity properly, would prevent spending money on the complications of obesity that currently cost the NHS 6 billion per year
Levtchenko E, Servais A, Hulton SA, Ariceta G, Emma F, Game DS, Lange K, Lapatto R, Liang H, Sberro-Soussan R, Topaloglu R, Das AM, Webb NJA, Wanner C (2022) Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients
Diamond, I